Detalhe da pesquisa
1.
Epigenetic therapy inhibits metastases by disrupting premetastatic niches.
Nature
; 579(7798): 284-290, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32103175
2.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
N Engl J Med
; 386(21): 1973-1985, 2022 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-35403841
3.
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
Proc Natl Acad Sci U S A
; 118(37)2021 09 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34508005
4.
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.
Future Oncol
; 19(8): 549-557, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36815433
5.
Neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Clin Adv Hematol Oncol
; (8): 415-423, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37530615
6.
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
Oncologist
; 27(11): 971-981, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35972337
7.
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors.
Cancer Immunol Immunother
; 71(10): 2405-2420, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35217892
8.
PD-1 Blockade in Early-Stage Lung Cancer.
Annu Rev Med
; 70: 425-435, 2019 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30355264
9.
Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies.
Oncologist
; 26(10): e1822-e1832, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34251728
10.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med
; 378(21): 1976-1986, 2018 May 24.
Artigo
Inglês
| MEDLINE | ID: mdl-29658848
11.
Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy.
Cancer
; 126(20): 4572-4583, 2020 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32729962
12.
Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. Reply.
N Engl J Med
; 387(6): 572-573, 2022 08 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35947719
13.
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation.
Ann Rheum Dis
; 79(3): 332-338, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31540935
14.
Immunotherapy for mesothelioma: rationale and new approaches.
Clin Adv Hematol Oncol
; 18(9): 562-572, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-33006585
15.
A Multidisciplinary Toxicity Team for Cancer Immunotherapy-Related Adverse Events.
J Natl Compr Canc Netw
; 17(6): 712-720, 2019 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31200355
16.
Use of Immune Checkpoint Inhibitors in Mesothelioma.
Curr Treat Options Oncol
; 20(2): 18, 2019 02 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30762130
17.
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer.
Oncologist
; 23(7): 859-865, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29487223
18.
Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer.
Oncology (Williston Park)
; 32(4): 156-63, 2018 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29684234
19.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med
; 379(9): e14, 2018 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30157404
20.
Managing acquired resistance in EGFR-mutated non-small cell lung cancer.
Clin Adv Hematol Oncol
; 13(8): 528-32, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26351816